8:30 |
Welcoming Address |
8:35 |
Research, Innovation and Partnership
France Dionne, Québec Government Representative
Québec Government Office in Boston |
|
Technology Presentations - Diagnostic Applications and Anti-infectives
|
N
E
T
W
O
R
K
I
N
G
|
O
N
E
O
N
O
N
E
|
 |
|
| 8:50 |
Diagnostic for Transplantation: Graft vs Host Disease and Renal Transplantation
Anne-Marie Larose,  Univalor (VAL-652),  Video Presentation |
| 9:00 |
First in Class 5-OXO-ETE Receptor Antagonists
Michèle Beaulieu, McGill (09044), Video Presentation |
| 9:10 |
Gene Signatures to Identify Cirrhosis Patients at Risk for Liver Cancer and Predict Cancer Recurrence
Rahul Ballal, MTTC-Broad, Video Presentation |
| 9:20 |
Cancer Prognostic Markers and the Method for Finding Them
Edwin Wang, NRC-BRI (12020), Video Presentation |
| 9:30 |
A Chemistry Platform for Gene Silencing: Antisense and siRNA
Masad Damha, McGill (09065), Video Presentation |
| 9:40 |
Novel H1V-1 Protease Inhibitors
Celia A. Schiffer, MTTC - UMassMed, Video Presentation |
| 9:50 |
Multi-Modal Imaging Agents for Molecular Diagnosis of Cancer
Stacey Nunes, NRC-IBS (12075), Video Presentation |
| 10:00 |
Novel HSV2 Vaccine Technology
Feng Yao, MTTC-Brigham, Video Presentation |
| 10:10 |
Morning Coffee Break |
|
Technology Presentations - CNS, Ophthalmology and Gene Therapy |
| 10:30 |
Lodamin: A Novel Oral Drug for Oncology, Ophthalmology and Autoimmune Diseases
Ofra Benny-Ratsaby, MTTC-Children’s, Video Presentation |
| 10:40 |
Novel Peptide(s) for the Treatment of Alzheimer’s Disease
Stacey Nunes, NRC-IBS (11630), Video Presentation |
| 10:50 |
Trk Family Receptor Ligands for Treatment of Neurodegenerative Diseases
Uri Saragovi, McGill (10051), Video Presentation |
| 11:00 |
New Targets for Inflammatory Disease of the Nervous System Including Multiple Sclerosis
Anne-Marie Larose, Univalor (VAL-737), Video Presentation |
| 11:10 |
Bacterial Components for Allergic Airway Disorder Therapy
Yves Geoffrion, NRC-IBS (11894), Video Presentation |
| 11:20 |
New Target and Compounds for Treating Age-Related Macular Degeneration
Louis Provencher, Univalor (VAL-620), Video Presentation |
| 11:30 |
Muscle-Mediated Gene Therapy
Rénald Gilbert, NRC-BRI (11887), Video Presentation |
| 11:40 |
Atoxic Recombinant Holotoxins of Clostridium Difficile as Immunogens
Feng Hanping , MTTC - Tufts University, Video Presentation |
| 11:50 |
U.S. Venture Capital Investing in Canadian Life Science Companies - Challenges and Opportunities
Leonard M. Gold,
Partner, Chair of Canada Practice
Burns & Levinson LLP
Dr. Ronda P. Moore,
Partner, Intellectual Property/SciTech Group
Burns & Levinson LLP
|
| 12:10 |
Lunch and Networking |
|
Technology Presentations - Technology Platforms |
N
E
T
W
O
R
K
I
N
G
|
O
N
E
O
N
O
N
E
|
|
|
| 13:10 |
HEK293 Cell Line for Industrial Production of Recombinant Proteins, Viral Vectors and Vaccines
Bernard Massie, NRC-BRI (10894), Video Presentation |
| 13:20 |
A New Platform for Generating Optimized Peptides Library
Anne-Marie Larose, Univalor (VAL-708), Video Presentation |
| 13:30 |
Vaccine Adjuvant Platform
Olivia Novac, McGill (10084), Video Presentation |
| 13:40 |
Human Soluble VH and VL Single-Domain Antibody Libraries for Human Therapeutic Applications
Jamshid Tanha, NRC-IBS (11686), Video Presentation |
| 13:50 |
Platform Technology for Small Molecule Modulators of Autophagy
Junying Yuan, MTTC-Harvard, Video Presentation |
| 14:00 |
Cumate-Inducible Expression System in Eukaryotic Cells
Benard Massie, NRC-BRI (11648), Video Presentation |
| 14:10 |
A New Vaccine Platform to Ensure Epitope Delivery for both MHC Presentation (e.g. Hepatitis C Novel Antigen)
Louis Provencher, Univalor (VAL-678), Video Presentation |
| 14:20 |
Synthetic Ether Lipid (Archaeosome) Delivery/Adjuvant Technology
Yves Geoffrion, NRC-IBS (11784), Video Presentation |
| 14:30 |
Efficient, Fast and Productive Method for Large-Scale Transfection of CHO and HEK293 Cells
Yves Durocher, NRC-BRI (11992), Video Presentation |
| 14:40 |
Engineered Biosynthetic Pathway for Sialic Acid Analogs and its Use for the Development of Anti-Infectives
Ian Schoenhofen, NRC-IBS (12033), Video Presentation |
| 14:50 |
Afternoon Coffee Break |
|
Technology Presentations - Oncology and Transplantation |
| 15:10 |
Chemosensitizing Agents for Multidrug Resistance (MDR) & Chemotherapy
Larry Chow, McGill (09086), Video Presentation |
| 15:20 |
TGF-β Biologic Targeted Therapy for Oncology, Cardiovascular Disease and Nephrology Indications
Maureen O’Connor, NRC-BRI (11817), Video Presentation |
| 15:30 |
Use of Novel Proteasome Inhibitors to Treat Cancer and Disorders in the Immune System
Clermont Beaulieu, Univalor (VAL-789), Video Presentation |
| 15:40 |
Novel Peptide(s) for the Treatment of Cancer
Danica Stanimirovic, NRC-IBS (11627), Video Presentation |
| 15:50 |
A Simple, Scalable and High Yield Method for High Level Production of Human Recombinant Interferon
Yves Durocher, NRC-BRI (11993), Video Presentation |
| 16:00 |
Fusion Protein Platform: Anti-Cancer, Anti-Inflammatory and Immunosuppressive
Jacques Galipeau, McGill (06087), Video Presentation |
| 16:10 |
Antimetabolites C3’
Louis Provencher, Univalor (VAL-740), Video Presentation |
| 16:20 |
Novel Anti-Mitotic Peptides for the Treatment of Cancer
Giovanna Sebastiani, McGill (04086), Video Presentation |
| 16:30 |
Expansion of Hematopoeitic Stem Cells
Carla DeMaria, MTTC-Whitehead, Video Presentation |
16:40
 |
Title of the Presentation to be Confirmed
Philip McGurk, Senior Director, Worldwide Business Development
Pfizer Inc.
|
| 17:00 |
Cocktail |
